Inactief instrument

Andere talen Guided Therapeutics Inc OTC Bulletin Board

Aandelen

US40171F3038

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results	20/02
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	20/11
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	20/11
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval	01-05-23
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30-03-23
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)	30-03-23
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	30-03-23
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation	15-03-23
Guided Therapeutics, Inc. Announces CEO Changes	09-03-23
Guided Therapeutics, Inc. Announces Executive Changes	09-03-23
GUIDED THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)	09-03-23
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	21-12-22
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	21-12-22
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14-11-22
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan	09-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Guided Therapeutics Inc OTC Bulletin Board

Aandelen

US40171F3038

Andere talen

Filters